Trademarkia Logo

Canada

C$
ZEPOSIA
REGISTERED

on 7 Dec 2018

Last Applicant/ Owned by

RECEPTOS LLC

430 East 29th StreetNew York NY 10016

US

Serial Number

1828438 filed on 21st Mar 2017

Registration Number

TMA1010702 registered on 7th Dec 2018

Registration expiry Date

7th Dec 2033

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

ZEPOSIA

Trademark usage description

pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease namely inflammatory bowel diseases, inflammatory connectiv Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease namely inflammatory bowel diseases, inflammatory connective tissue diseases, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, pharmaceutical preparations for the treatment of musculoskeletal system namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases, immunologic deficiency syndromes, hematological tumors and solid tumors.


Classification kind code

11

Mark Details


Serial Number

1828438

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 15th Aug 2018
Advertised
Submitted for opposition 26
on 26th Jul 2018
Approved
Submitted for opposition 27
on 7th Jun 2018
Approval Notice Sent
Submitted for opposition 87
on 19th Apr 2018
Rep for Service Changed
Submitted for opposition 48
on 19th Apr 2018
Agent Changed
Submitted for opposition 22
on 11th Jan 2018
Search Recorded
Submitted for opposition 20
on 11th Jan 2018
Examiner's First Report
Submitted for opposition 31
on 27th Mar 2017
Formalized
Submitted for opposition 1
on 22nd Mar 2017
Created
Submitted for opposition 30
on 21st Mar 2017
Filed